High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 - PubMed (original) (raw)
High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1
A Sewing et al. Mol Cell Biol. 1997 Sep.
Abstract
Activated Raf has been linked to such opposing cellular responses as the induction of DNA synthesis and the inhibition of proliferation. However, it remains unclear how such a switch in signal specificity is regulated. We have addressed this question with a regulatable Raf-androgen receptor fusion protein in murine fibroblasts. We show that Raf can cause a G1-specific cell cycle arrest through induction of p21Cip1. This in turn leads to inhibition of cyclin D- and cyclin E-dependent kinases and an accumulation of hypophosphorylated Rb. Importantly, this behavior can be observed only in response to a strong Raf signal. In contrast, moderate Raf activity induces DNA synthesis and is sufficient to induce cyclin D expression. Therefore, Raf signal specificity can be determined by modulation of signal strength presumably through the induction of distinct protein expression patterns. Similar to induction of Raf, a strong induction of activated Ras via a tetracycline-dependent promoter also causes inhibition of proliferation and p21Cip1 induction at high expression levels. Thus, p21Cip1 plays a key role in determining cellular responses to Ras and Raf signalling. As predicted by this finding we show that Ras and loss of p21 cooperate to confer a proliferative advantage to mouse embryo fibroblasts.
Similar articles
- Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.
Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Woods D, et al. Mol Cell Biol. 1997 Sep;17(9):5598-611. doi: 10.1128/MCB.17.9.5598. Mol Cell Biol. 1997. PMID: 9271435 Free PMC article. - Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway.
Pumiglia KM, Decker SJ. Pumiglia KM, et al. Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):448-52. doi: 10.1073/pnas.94.2.448. Proc Natl Acad Sci U S A. 1997. PMID: 9012803 Free PMC article. - Cooperating oncogenes converge to regulate cyclin/cdk complexes.
Lloyd AC, Obermüller F, Staddon S, Barth CF, McMahon M, Land H. Lloyd AC, et al. Genes Dev. 1997 Mar 1;11(5):663-77. doi: 10.1101/gad.11.5.663. Genes Dev. 1997. PMID: 9119230 - Senescence of human fibroblasts induced by oncogenic Raf.
Zhu J, Woods D, McMahon M, Bishop JM. Zhu J, et al. Genes Dev. 1998 Oct 1;12(19):2997-3007. doi: 10.1101/gad.12.19.2997. Genes Dev. 1998. PMID: 9765202 Free PMC article. - Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
Marshall M. Marshall M. Mol Reprod Dev. 1995 Dec;42(4):493-9. doi: 10.1002/mrd.1080420418. Mol Reprod Dev. 1995. PMID: 8607981 Review.
Cited by
- Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication.
Guerrero Zuniga A, Aikin TJ, McKenney C, Lendner Y, Phung A, Hook PW, Meltzer A, Timp W, Regot S. Guerrero Zuniga A, et al. Dev Cell. 2024 Jul 8;59(13):1724-1736.e4. doi: 10.1016/j.devcel.2024.03.032. Epub 2024 Apr 18. Dev Cell. 2024. PMID: 38640927 - Disruption of the Mammalian Ccr4-Not Complex Contributes to Transcription-Mediated Genome Instability.
Hagkarim NC, Hajkarim MC, Suzuki T, Fujiwara T, Winkler GS, Stewart GS, Grand RJ. Hagkarim NC, et al. Cells. 2023 Jul 17;12(14):1868. doi: 10.3390/cells12141868. Cells. 2023. PMID: 37508532 Free PMC article. - Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.
Zuo C, Baer JM, Knolhoff BL, Belle JI, Liu X, Alarcon De La Lastra A, Fu C, Hogg GD, Kingston NL, Breden MA, Dodhiawala PB, Zhou DC, Lander VE, James CA, Ding L, Lim KH, Fields RC, Hawkins WG, Weber JD, Zhao G, DeNardo DG. Zuo C, et al. J Exp Med. 2023 Jun 5;220(6):e20212062. doi: 10.1084/jem.20212062. Epub 2023 Mar 23. J Exp Med. 2023. PMID: 36951731 Free PMC article. - The Predictive and Prognostic Role of RAS-RAF-MEK-ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets.
Rocca A, Braga L, Volpe MC, Maiocchi S, Generali D. Rocca A, et al. Cancers (Basel). 2022 Oct 28;14(21):5306. doi: 10.3390/cancers14215306. Cancers (Basel). 2022. PMID: 36358725 Free PMC article. Review. - Resistance to ERK1/2 pathway inhibitors; sweet spots, fitness deficits and drug addiction.
Sale MJ, Balmanno K, Cook SJ. Sale MJ, et al. Cancer Drug Resist. 2019 Jun 19;2(2):365-380. doi: 10.20517/cdr.2019.14. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582726 Free PMC article.
References
- Oncogene. 1996 Jan 4;12(1):127-34 - PubMed
- Oncogene. 1996 Jan 4;12(1):177-85 - PubMed
- Genes Dev. 1996 Apr 1;10(7):804-15 - PubMed
- Mol Cell Biol. 1996 Jun;16(6):2830-7 - PubMed
- Oncogene. 1996 Mar 21;12(6):1347-56 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous